Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

Halozyme faces late-stage pancreatic cancer drug failure, cuts 55% of jobs

Halozyme faces late-stage pancreatic cancer drug failure, cuts 55% of jobs

Will now focus on its novel drug delivery platform to drive business growth. ... As part of the re-focus strategy, Halozyme will now wholly concentrate on its ENHANZE drug delivery technology, with its remaining 120 employees driving the growth of the

Latest news

More from news
Approximately 2 fully matching, plus 177 partially matching documents found.

Latest Intelligence

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The analysis was confined to pharmaceutical and biopharmaceutical products, with innovation in drug delivery, devices and diagnostics considered as out of scope. ... Bio-pharma Manufacturers Association (KPBMA) is investing in an AI platform for drug

  • For trials without tribulations, we must improve patient experience For trials without tribulations, we must improve patient experience

    The old clinical trial model was well adapted to the blockbuster era of drug discovery and delivery. ... But the simpler ‘find patients, test drug’ era has well and truly passed.

  • Launch trends 2019 Launch trends 2019

    What are the big trends in pharma and biotech drug launches for 2019? ... This requires a shift from a ‘drug company’ to a ‘care delivery’ mindset, and manufacturers should begin planning for the commercialisation considerations early in the

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam was also forced to abandon one of its first pipeline drugs, revusiran, after it was linked to deaths in trials, but persisted, developing a safer and more potent drug delivery ... platform. Led by founder and CEO John Maraganore, Alynlam finally

  • Digging deeper to connect with the powerful force of patient understanding Digging deeper to connect with the powerful force of patient understanding

    The global pharmaceutical industry spends more than 2bn on market research to provide insights that herald business advantages as well as improve drug delivery despite the current climate of challenging budgets. ... Of course, we need efficacy to have a

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Edward Hæggström, CEO of Nanoform said: “Andrade’s background and experience in drug delivery will be a huge asset to the company. ... Tara Rheault. Rheault has more than 16 years of cross-functional leadership experience across drug discovery and

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    He was previously GM at Philips Respironics Respiratory Drug Delivery. Technology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief ... McGuire was previously Philips' general

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their experience to advise Catalent, a leading

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Diagnosing the lag in neuropsychiatric treatments

    To say the BBB presents a formidable challenge in CNS drug development is an understatement. ... Recent studies have investigated the use of biotechnology and nanotechnology for targeting CNS drug delivery, for example looking at whether biopolymeric

  • Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

    The changes to the drug-delivery system will be the advanced VLA and OncoSec’s next-generation generator. ... The VLA is not an implantable device, it is not life sustaining, and it is not of “substantial importance” in treating disease—it is a

  • Patient Centricity: Turning Rhetoric into Reality

    However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from ... drug discovery through to long-term disease

  • Creative Medical Research Creative Medical Research

    Diabetes. Pulmonary. Anaesthesia. Surgical. Drug delivery. Patient warming. Diagnostics.and vascular access to name but a few. ... Infusion. Vascular access. Surgical consummables. Diagnostics and monitoring. Drug delivery. Specific therapy areas we've

  • Catalent

    From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics